ArticleMolecular cancer therapeutics2015

Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression.

Zhiqun Shang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.